Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De-escalated Radiotherapy; Head and Neck Cancer”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Large-scale testing (Phase 3)Study completedNCT02908477
What this trial is testing

Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
Mayo Clinic 228
Testing effectiveness (Phase 2)Looking for participantsNCT05388773
What this trial is testing

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
Heath Skinner 150
Not applicableLooking for participantsNCT05854823
What this trial is testing

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Not applicableLooking for participantsNCT06313450
What this trial is testing

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapy; ComplicationsIMMUNOTHERAPY
Sun Yat-sen University 112
Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91
Testing effectiveness (Phase 2)Looking for participantsNCT05541016
What this trial is testing

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+4 more
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06353685
What this trial is testing

De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.

Who this might be right for
De-escalated Radiotherapy; Head and Neck Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 103
Testing effectiveness (Phase 2)Study completedNCT03715946
What this trial is testing

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckOropharynx Squamous Cell Carcinoma
Robert L. Ferris, MD, PhD 40
Not applicableActive Not RecruitingNCT03777384
What this trial is testing

EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers

Who this might be right for
Oropharyngeal Cancer
Sanford Health 75
455